Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $2.631B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| NTRA | Natera Inc | 1,550,280 | $310M | 11.8% | $199.99 * | $9.81 | +2202.8% | COM | 632307104 |
| IWM | iShares TR | 600,000 | $149M | 5.7% | $248.00 | — | — | Put | 464287655 |
| XBI | SPDR Series Trust | 1,050,000 | $134M | 5.1% | $127.73 | — | — | Put | 78464A870 |
| BMY | Bristol-Myers Squibb Co | 1,988,721 | $121M | 4.6% | $60.65 * | $49.89 | +15.1% | COM | 110122108 |
| JAZZ | Jazz Pharmaceuticals PLC | 598,327 | $113M | 4.3% | $189.05 * | $128.75 | +31.3% | SHS USD | G50871105 |
| VERA | Vera Therapeutics Inc | 2,793,987 | $112M | 4.3% | $40.23 * | $15.35 | +192.9% | CL A | 92337R101 |
| UTHR | United Therapeutics Corp | 160,070 | $94.92M | 3.6% | $592.98 * | $315.57 | +52.2% | COM | 91307C102 |
| AZN | AstraZeneca PLC | 456,031 | $89.94M | 3.4% | $197.22 * | $190.39 | 0.0% | ORD | G0593M107 |
| QQQ | Invesco QQQ TR | 150,000 | $86.58M | 3.3% | $577.18 | — | — | Put | 46090E103 |
| COGT | Cogent Biosciences Inc | 2,113,551 | $81.35M | 3.1% | $38.49 * | $9.16 | +308.1% | COM | 19240Q201 |
| IBB | iShares TR | 475,000 | $80.2M | 3.0% | $168.85 | — | — | Put | 464287556 |
| RARE | Ultragenyx Pharmaceutical Inc | 3,145,888 | $65.91M | 2.5% | $20.95 * | $23.61 | -1.1% | COM | 90400D108 |
| RAPP | Rapport Therapeutics Inc | 1,904,408 | $59.59M | 2.3% | $31.29 * | $23.12 | +20.4% | COM | 75383L102 |
| INSM | Insmed Inc | 346,075 | $56.59M | 2.2% | $163.52 * | $130.18 | +22.2% | COM PAR $.01 | 457669307 |
| ALC | Alcon AG | 729,972 | $55M | 2.1% | $75.35 * | $78.89 | +2.0% | ORD SHS | H01301128 |
| SUPN | Supernus Pharmaceuticals | 954,309 | $49.33M | 1.9% | $51.69 * | $43.73 | +15.5% | COM | 868459108 |
| UTHR | United Therapeutics Corp | 80,300 | $47.62M | 1.8% | $592.98 * | $315.57 | +52.2% | Put | 91307C102 |
| BMRN | BioMarin Pharmaceutical Inc | 781,982 | $44.17M | 1.7% | $56.49 * | $54.91 | +6.9% | COM | 09061G101 |
| BIIB | Biogen Inc | 229,521 | $42.08M | 1.6% | $183.33 | $183.25 | 0.0% | COM | 09062X103 |
| CELC | Celcuity Inc | 366,175 | $41.8M | 1.6% | $114.14 * | $57.62 | +86.5% | COM | 15102K100 |
| BIOA | BioAge Labs Inc | 2,293,788 | $40.12M | 1.5% | $17.49 * | $20.04 | -4.2% | COM | 09077V100 |
| RYTM | Rhythm Pharmaceuticals Inc | 450,096 | $39.14M | 1.5% | $86.97 * | $75.79 | +35.7% | COM | 76243J105 |
| AVBP | Arrivent BioPharma Inc | 1,696,752 | $39.14M | 1.5% | $23.07 * | $20.17 | +9.4% | COM | 04272N102 |
| IDYA | IDEAYA Biosciences Inc | 1,131,786 | $37.71M | 1.4% | $33.32 | $27.20 | +24.5% | COM | 45166A102 |
| IMNM | Immunome Inc | 1,701,904 | $37.22M | 1.4% | $21.87 * | $18.06 | +27.8% | COM | 45257U108 |
| NKTR | Nektar Therapeutics | 509,546 | $36.66M | 1.4% | $71.95 * | $49.59 | -2.5% | COM | 640268306 |
| AXSM | Axsome Therapeutics Inc. | 212,747 | $35.96M | 1.4% | $169.02 * | $175.92 | +2.5% | COM | 05464T104 |
| IMTX | Immatics N.V | 3,630,454 | $35.72M | 1.4% | $9.84 | $7.47 | +31.3% | SHS | N44445109 |
| CELC | Celcuity Inc | 300,000 | $34.24M | 1.3% | $114.14 * | $57.62 | +86.5% | Put | 15102K100 |
| AXSM | Axsome Therapeutics Inc. | 200,000 | $33.8M | 1.3% | $169.02 * | $175.92 | +2.5% | Put | 05464T104 |
| BBIO | BridgeBio Pharma Inc | 409,183 | $30.39M | 1.2% | $74.26 | $34.41 | +116.4% | COM | 10806X102 |
| DYN | Dyne Therapeutics Inc | 1,633,897 | $29.62M | 1.1% | $18.13 * | $18.03 | -5.0% | COM | 26818M108 |
| INBX | Inhibrx Biosciences Inc | 406,029 | $27.3M | 1.0% | $67.23 * | $16.63 | +367.3% | COM | 45720N103 |
| DXCM | Dexcom Inc | 393,576 | $24.72M | 0.9% | $62.80 * | $77.19 | -8.1% | COM | 252131107 |
| PHVS | Pharvaris N V | 818,328 | $23.12M | 0.9% | $28.25 * | $21.59 | +23.9% | COM | N69605108 |
| PFE | Pfizer Inc | 800,000 | $22.46M | 0.9% | $28.08 | — | — | Call | 717081103 |
| PRAX | Praxis Precision Medicines Inc | 63,680 | $20.52M | 0.8% | $322.19 * | $49.76 | +526.7% | COM | 74006W207 |
| GMAB | Genmab A/S | 752,261 | $20.18M | 0.8% | $26.83 | $26.83 | — | SPONSORED ADS | 372303206 |
| RCUS | Arcus Biosciences Inc | 923,086 | $19.94M | 0.8% | $21.60 | $11.15 | +90.9% | COM | 03969F109 |
| LQDA | Liquidia Corporation | 500,000 | $18.87M | 0.7% | $37.74 | — | — | Put | 53635D202 |
| XENE | Xenon Pharmaceuticals Inc | 305,216 | $17.75M | 0.7% | $58.15 * | $41.99 | -0.0% | COM | 98420N105 |
| SYK | Stryker Corporation | 44,480 | $14.62M | 0.6% | $328.59 * | $364.67 | 0.0% | COM | 863667101 |
| ANAB | AnaptysBio Inc | 248,253 | $13.77M | 0.5% | $55.46 * | $20.04 | +146.4% | COM | 032724106 |
| ROIV | Roivant Sciences Ltd | 477,995 | $13.24M | 0.5% | $27.70 * | $10.86 | +122.6% | SHS | G76279101 |
| EWTX | Edgewise Therapeutics Inc | 386,498 | $12.17M | 0.5% | $31.50 * | $16.17 | +74.3% | COM | 28036F105 |
| CMPX | Compass Therapeutics Inc | 2,056,161 | $10.88M | 0.4% | $5.29 * | $3.74 | +60.5% | COM | 20454B104 |
| EXEL | Exelixis Inc | 251,500 | $10.79M | 0.4% | $42.89 | — | — | Put | 30161Q104 |
| ORIC | Oric Pharmaceuticals Inc | 679,578 | $8.61M | 0.3% | $12.67 * | $10.77 | 0.0% | COM | 68622P109 |
| TNGX | Tango Therapeutics Inc | 395,081 | $8.265M | 0.3% | $20.92 * | $11.91 | 0.0% | COM | 87583X109 |
| TYRA | Tyra Biosciences Inc | 204,015 | $7.814M | 0.3% | $38.30 * | $30.25 | 0.0% | COM | 90240B106 |
| REPL | Replimune Group Inc | 1,015,400 | $7.768M | 0.3% | $7.65 | — | — | Call | 76029N106 |
| RARE | Ultragenyx Pharmaceutical Inc | 350,000 | $7.332M | 0.3% | $20.95 * | $23.61 | -1.1% | Call | 90400D108 |
| AXGN | AxoGen Inc | 210,665 | $6.979M | 0.3% | $33.13 | $33.29 | 0.0% | COM | 05463X106 |
| DFTX | Definium Therapeutics Inc | 344,166 | $6.505M | 0.2% | $18.90 * | $16.29 | 0.0% | COM SHS | 24477V105 |
| CYTK | Cytokinetics Inc | 91,791 | $6.05M | 0.2% | $65.91 * | $64.44 | 0.0% | COM | 23282W605 |
| IRON | Disc Medicine Inc | 78,320 | $5.008M | 0.2% | $63.94 * | $80.32 | -7.8% | COM | 254604101 |
| MANE | Veradermics Inc | 73,315 | $4.63M | 0.2% | $63.15 | $63.15 | — | COMMON STOCK | 922967104 |
| HRMY | Harmony Biosciences Hldgs Inc | 152,695 | $4.277M | 0.2% | $28.01 * | $35.68 | 0.0% | COM | 413197104 |
| PCVX | Vaxcyte Inc | 50,600 | $2.94M | 0.1% | $58.11 * | $52.77 | 0.0% | COM | 92243G108 |
| CMPX | Compass Therapeutics Inc | 500,000 | $2.645M | 0.1% | $5.29 * | $3.74 | +60.5% | Call | 20454B104 |
| MIRM | Mirum Pharmaceuticals Inc | 27,591 | $2.549M | 0.1% | $92.38 * | $75.81 | +27.4% | COM | 604749101 |
| NXTC | Nextcure Inc | 222,654 | $2.378M | 0.1% | $10.68 * | $5.23 | +140.4% | COM | 65343E207 |
| SVRA | Savara Inc | 364,763 | $1.992M | 0.1% | $5.46 * | $4.42 | +28.9% | COM | 805111101 |
| ESTA | Establishment Labs Hldgs Inc | 33,930 | $1.927M | 0.1% | $56.78 * | $57.81 | +21.7% | COM | G31249108 |
| ACAD | Acadia Pharmaceuticals Inc | 78,551 | $1.749M | 0.1% | $22.26 * | $24.03 | +4.9% | COM | 004225108 |
| TENX | Tenax Therapeutics Inc | 104,400 | $1.669M | 0.1% | $15.99 * | $13.50 | 0.0% | COM | 88032L605 |
| JBIO | Jade Biosciences Inc | 107,391 | $1.509M | 0.1% | $14.05 * | $33.31 | -55.6% | COM | 008064206 |
| WVE | Wave Life Sciences Ltd | 189,253 | $1.372M | 0.1% | $7.25 * | $8.16 | +68.5% | SHS | Y95308105 |
| SEPN | Septerna Inc | 47,506 | $1.142M | 0.0% | $24.03 * | $26.51 | 0.0% | COM | 81734D104 |
| OKUR | Onkure Therapeutics Inc | 141,700 | $587K | 0.0% | $4.14 * | $2.73 | 0.0% | COM CL A | 68277Q105 |
| BOLT | Bolt Biotherapeutics Inc | 137,721 | $556K | 0.0% | $4.04 * | $6.62 | -13.4% | COM | 097702203 |
| SLNO | Soleno Therapeutics Inc | 14,689 | $492K | 0.0% | $33.48 * | $44.72 | -6.9% | COM | 834203309 |
| IMA | ImageneBio Inc | 31,884 | $159K | 0.0% | $5.00 * | $13.25 | -47.9% | COM | 45175G207 |
| ZYME | Zymeworks Inc | 1,610 | $40,314 | 0.0% | $25.04 * | $23.38 | 0.0% | COM | 98985Y108 |